Abstract Details
|
Adam De Havenon, MD, FAAN
(Yale University)
PRESENTER |
Dr. De Havenon has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Novo Nordisk. Dr. De Havenon has or had stock in Certus.Dr. De Havenon has or had stock in TitinKM. The institution of Dr. De Havenon has received research support from NIH/NINDS. Dr. De Havenon has received publishing royalties from a publication relating to health care. |
| Alen Delic | Alen Delic has nothing to disclose. |
| No disclosure on file | |
| Vivek Reddy, MD (University of Utah) | Dr. Reddy has nothing to disclose. |
| No disclosure on file | |
| Jennifer J. Majersik, MD, FAAN (University of Utah) | Dr. Majersik has received personal compensation in the range of $10,000-$49,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Stroke. The institution of Dr. Majersik has received research support from NIH/NINDS. The institution of Dr. Majersik has received research support from NIH/NCATS. |
| Christopher Orlando, MD, MPH | Dr. Orlando has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Genentech. |